OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology Reviews is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Antimicrobial Resistance in ESKAPE Pathogens	920
Coronavirus Disease 2019–COVID-19	661
New β-Lactam–β-Lactamase Inhibitor Combinations	249
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection	200
Remdesivir against COVID-19 and Other Viral Diseases	169
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	160
Antifungal Susceptibility Testing: Current Approaches	142
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection	136
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis	127
Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory	124
Host-Directed Antiviral Therapy	107
Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries	105
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	98
Pathogenesis of Gram-Negative Bacteremia	98
Yersinia pestis: the Natural History of Plague	93
Microsporidiosis in Humans	91
The Changing Face of the Family Enterobacteriaceae (Order: “ Enterobacterales ”): New Members, Taxonomic Issues, Geographic Expansion, and	86
Convalescent Plasma Therapy for COVID-19: State of the Art	86
Evolutionary Pathways and Trajectories in Antibiotic Resistance	78
Advances in the Microbiology of Stenotrophomonas maltophilia	78
Viral Respiratory Pathogens and Lung Injury	77
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis	72
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies	71
Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products	69
Pathogenesis of Respiratory Viral and Fungal Coinfections	66

Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis	65
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	64
Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters	64
Intrathecal Antibacterial and Antifungal Therapies	61
Laboratory Diagnosis of Lyme Borreliosis	61
SARS-CoV-2 Antiviral Therapy	59
Giardia duodenalis: Biology and Pathogenesis	56
Taenia solium Cysticercosis and Its Impact in Neurological Disease	55
Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries	55
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	50
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation	46
Human Listeriosis	45
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices	45
Staphylococcus lugdunensis: a Skin Commensal with Invasive Pathogenic Potential	45
Interplay between Candida albicans and Lactic Acid Bacteria in the Gastrointestinal Tract: Impact on Colonization Resistance, Microbial Carriage, Opportunistic Infection, and Host Immunity	41
SARS-CoV-2 and Health Care Worker Protection in Low-Risk Settings: a Review of Modes of Transmission and a Novel Airborne Model Involving Inhalable Particles	41
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	40
Staphylococcus aureus in Agriculture: Lessons in Evolution from a Multispecies Pathogen	40
The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections	39
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	36
Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance	35
Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients	34
Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation	34
Device-Associated Menstrual Toxic Shock Syndrome	33
Updated Review onNocardiaSpecies: 2006–2021	32
Understanding the Impact of Resistance to Influenza Antivirals	31
State of the Art in the Culture of the Human Microbiota: New Interests and Strategies	31
The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications	31
Canine and Feline Parasitology: Analogies, Differences, and Relevance for Human Health	30
Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks	29
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection	29
Monkeypox Virus Infections in Humans	28
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies	27
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis	27
Antiviral Approaches against Influenza Virus	26
Echinococcoses in Iran, Turkey, and Pakistan: Old Diseases in the New Millennium	25
Aspergillus terreus Species Complex	25
Paracoccidioidomycosis: Current Status and Future Trends	25
SARS-CoV-2 Infection and Lung Regeneration	25
Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection	24
The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures	23
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease	22
Group B Streptococcal Neonatal Meningitis	22
Erratum for Yahav et al., “New β-Lactam–β-Lactamase Inhibitor Combinations”	21
Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections	20
Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use	20
Erratum for Ramasamy and Subbian, “Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis”	20
Diagnosis, Management, and Future Control of Cholera	19
Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy	19
Class C β-Lactamases: Molecular Characteristics	16

Natural-Product-Based Solutions for Tropical Infectious Diseases	16
Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases	15
An Overlooked and Underrated Endemic Mycosis—Talaromycosis and the Pathogenic Fungus Talaromyces marneffei	15
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases	15